Shah G - Search Results

1

Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor.

Thomas S, Chigurupati S, Anbalagan M, Shah G. Thomas S, et al. Among authors: shah g. Mol Endocrinol. 2006 Aug;20(8):1894-911. doi: 10.1210/me.2005-0284. Epub 2006 Mar 30. Mol Endocrinol. 2006. PMID: 16574742

2

Targeted overexpression of calcitonin in gonadotrophs of transgenic mice leads to chronic hypoprolactinemia.

Yuan R, Kulkarni T, Wei F, Shah GV. Yuan R, et al. Mol Cell Endocrinol. 2005 Jan 14;229(1-2):193-203. doi: 10.1016/j.mce.2004.06.013. Mol Cell Endocrinol. 2005. PMID: 15607543

3

Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action.

Sabbisetti VS, Chirugupati S, Thomas S, Vaidya KS, Reardon D, Chiriva-Internati M, Iczkowski KA, Shah GV. Sabbisetti VS, et al. Int J Cancer. 2005 Nov 20;117(4):551-60. doi: 10.1002/ijc.21158. Int J Cancer. 2005. PMID: 15929083

4

Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells.

Chigurupati S, Kulkarni T, Thomas S, Shah G. Chigurupati S, et al. Among authors: shah g. Cancer Res. 2005 Sep 15;65(18):8519-29. doi: 10.1158/0008-5472.CAN-05-0848. Cancer Res. 2005. PMID: 16166333

5

Calcitonin induces apoptosis resistance in prostate cancer cell lines against cytotoxic drugs via the Akt/survivin pathway.

Thomas S, Shah G. Thomas S, et al. Among authors: shah g. Cancer Biol Ther. 2005 Nov;4(11):1226-33. doi: 10.4161/cbt.4.11.2093. Epub 2005 Nov 5. Cancer Biol Ther. 2005. PMID: 16222118 Free article.

6

Calcitonin stimulates the secretion of urokinase-type plasminogen activator from prostate cancer cells: its possible implications on tumor cell invasion.

Sabbisetti V, Chigurupati S, Thomas S, Shah G. Sabbisetti V, et al. Among authors: shah g. Int J Cancer. 2006 Jun 1;118(11):2694-702. doi: 10.1002/ijc.21625. Int J Cancer. 2006. PMID: 16381004

7

Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling.

Thomas S, Chiriva-Internati M, Shah GV. Thomas S, et al. Clin Exp Metastasis. 2007;24(5):363-77. doi: 10.1007/s10585-007-9073-y. Epub 2007 May 9. Clin Exp Metastasis. 2007. PMID: 17487556

8

A synthetic peptide derived from mouse pituitary calcitonin cDNA sequence exhibits potent inhibition of prolactin secretion and prolactin mRNA abundance in primary mouse pituitary cells.

Kulkarni-Paranjape T, Shah GV. Kulkarni-Paranjape T, et al. Endocrine. 2007 Jun;31(3):242-7. doi: 10.1007/s12020-007-0044-5. Endocrine. 2007. PMID: 17906370

9

Knock-down of calcitonin receptor expression induces apoptosis and growth arrest of prostate cancer cells.

Thomas S, Muralidharan A, Shah GV. Thomas S, et al. Int J Oncol. 2007 Dec;31(6):1425-37. Int J Oncol. 2007. PMID: 17982669

10

Biocatalytic and semisynthetic optimization of the anti-invasive tobacco (1S,2E,4R,6R,7E,11E)-2,7,11-cembratriene-4,6-diol.

El Sayed KA, Laphookhieo S, Baraka HN, Yousaf M, Hebert A, Bagaley D, Rainey FA, Muralidharan A, Thomas S, Shah GV. El Sayed KA, et al. Bioorg Med Chem. 2008 Mar 15;16(6):2886-93. doi: 10.1016/j.bmc.2007.12.056. Epub 2008 Jan 3. Bioorg Med Chem. 2008. PMID: 18222089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,425 results

Search Page

Filters